Rheumatoid Arthritis, Planned Behavıor Theory And Nurse Counselıng
Rheumatoid Arthritis
About this trial
This is an interventional supportive care trial for Rheumatoid Arthritis focused on measuring Planned Behavior Theory
Eligibility Criteria
Criteria:
Inclusion Criteria for Research
- Between 18 and 64 years old
- Diagnosed with Rheumatoid Arthritis at least 6 months ago,
- Can communicate in Turkish and does not have a cognitive problem that prevents communication,
- No neurological or psychiatric disease without malignancy,
- Without heart failure (stages III and IV according to NYHA)
- Not pregnant,
- Able to use a telephone,
- Patients who volunteer to participate in the study will be included in the study.
Exclusion Criteria
- Under 18 years old,
- Newly diagnosed, treated for less than 6 months,
- Having a malignant type of disease,
- Patients who do not volunteer to participate in the study will not be included.
Sites / Locations
- Hasan Kalyoncu Uninersity
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
training and consultancy
control
"Patient Description Form, Bristol Rheumatoid Arthritis Fatigue Multidimensional Questionnaire, McGill Pain Scale Short Form, Stanford Health Assessment Questionnaire" will be administered to the patients in this group at the first interview. Individual training will be given to the patient in line with the training guide prepared for the rheumatoid arthritis patient, and the guide will be shared after the training. In line with the theory of planned behavior in patients with rheumatoid arthritis, counseling service will be provided by the researcher to the extent of the training plan prepared for symptom management. At the end of the 3rd month, the patients will be interviewed face to face and the "Bristol Rheumatoid Arthritis Fatigue Multidimensional Questionnaire, McGill Pain Scale Short Form, Stanford Health Assessment Questionnaire" will be administered again.
After obtaining written consent from the patients who agreed to participate in the study, the patients included in the control group were asked to continue their rheumatologist follow-up and their normal lives (hospital routine, daily life). Patients in this group will fill out the "Patient Description Form, Bristol Rheumatoid Arthritis Fatigue Multidimensional Questionnaire, McGill Pain Scale Short Form, Stanford Health Evaluation Questionnaire" at the first interview. After 3 months, data collection tools other than the "Patient Identification Form" will be applied to the patients and the training guide to be prepared for rheumatoid arthritis patients will be given.